Advocacy at a Glance 5/8/20 Advocacy at a Glance 5/8/20 Advocacy at a Glance Read More Advocacy at a Glance 8/24/18 Advocacy at a Glance 8/24/18 Advocacy at a Glance Read More Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Sometimes There Really Is a Win-Win Read More Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Advocacy at a Glance Read More Advocacy at a Glance 6/29/18 Advocacy at a Glance 6/29/18 Advocacy at a Glance Read More Advocacy at a Glance 6/1/18 Advocacy at a Glance 6/1/18 Advocacy at a Glance Read More Advocacy at a Glance 12/1/17 Advocacy at a Glance 12/1/17 Advocacy at a Glance Read More Advocacy at a Glance 7/14/17 Advocacy at a Glance 7/14/17 Advocacy at a Glance Read More Advocacy at a Glance 6/29/17 Advocacy at a Glance 6/29/17 Advocacy at a Glance Read More Advocacy at a Glance 3/24/17 Advocacy at a Glance 3/24/17 Advocacy at a Glance Read More Advocacy at a Glance 12/16/16 Advocacy at a Glance 12/16/16 Advocacy at a Glance Read More Analysis and Commentary 12/8/16 Analysis and Commentary 12/8/16 Setting the Advocacy Stage for FY 18 and After Read More Advocacy at a Glance 12/8/16 Advocacy at a Glance 12/8/16 Advocacy at a Glance Read More Analysis and Commentary 12/5/16 Analysis and Commentary 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More Advocacy at a Glance 12/5/16 Advocacy at a Glance 12/5/16 Advocacy at a Glance Read More Advocacy at a Glance 10/1/16 Advocacy at a Glance 10/1/16 Advocacy at a Glance Read More Advocacy at a Glance 6/10/16 Advocacy at a Glance 6/10/16 Advocacy at a Glance Read More Advocacy at a Glance 4/22/16 Advocacy at a Glance 4/22/16 Advocacy at a Glance Read More Analysis and Commentary 4/15/16 Analysis and Commentary 4/15/16 Give Us Something We Can Support! Read More Analysis and Commentary 1/23/16 Analysis and Commentary 1/23/16 Why Have We Watched "Cures" So Closely? Read More Older Posts
Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Sometimes There Really Is a Win-Win Read More
Analysis and Commentary 12/8/16 Analysis and Commentary 12/8/16 Setting the Advocacy Stage for FY 18 and After Read More
Analysis and Commentary 12/5/16 Analysis and Commentary 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More
Analysis and Commentary 4/15/16 Analysis and Commentary 4/15/16 Give Us Something We Can Support! Read More
Analysis and Commentary 1/23/16 Analysis and Commentary 1/23/16 Why Have We Watched "Cures" So Closely? Read More
